Cell Therapy Options at Guang-Li Biomedicine and Taipei Medical University Hospital Bring Hope to Cancer Patients

The immunotherapy used by Guang-Li Biomedicine and Taipei Medical University Hospital brings new hope to the terminal patients of solid cancer.

Taipei, Taiwan (Merxwire) – The international journals Cell and Science have reported that immune cell therapy is a new generation of anti-cancer weapons. The immuno-cell therapy developed by Guang-Li Biomedicine and Taipei Medical University Hospital uses the human body’s immune system to attack tumor cells. This major breakthrough in cancer treatment has prolonged the life of many cancer patients who were previously incurable and even cured them.

With cell therapy officially allowed in Taiwan, Guang-Li Biomedicine and Taipei Medical University Hospital are leading Taiwan’s many medical institutions and research units in legalizing cancer treatment programs. The Guang-Li Experimental Center took advantage of stem cell storage patents and immune cell preparation technology and successfully summited application and received approval of CIK immune cell therapy for 12 solid cancers, bringing top medical technology to patients.

 

Lee, Kuan-Der, deputy dean of Taipei Medical University Hospital, said that the clinical trial of the hospital and Guang-Li Biomedicine has been approved and highly active Cytokine-induced killer cells (CIK) can be used on first- to third-stage cancer patients that do not respond to treatment effectively, as well as patients in the fourth phase of solid cancer, which is currently a more effective way to prolong life and cure cancer than other therapies.

The indication of approved projects include: colorectal cancer, breast cancer, lung cancer, cervical cancer, ovarian cancer, kidney cancer, liver cancer, pancreatic cancer, nasopharyngeal cancer, stomach cancer, esophageal cancer, and cholangiocarcinoma.

Taiwan has top cell therapy technology

In the past, cancer treatment, regardless of surgery, chemotherapy, radiation therapy, is to remove tumor cells from the outside, but Taiwanese law already allows the use of autologous cells for autoimmune cell therapy, and there are many successful cases for patients with stable cancer. In addition, Taiwan has also opened up autologous chondrocyte transplantation, autologous fat stem cell transplantation, skin repair, wound healing, and articular cartilage regeneration.

About Taipei Medical University Hospital

Taipei Medical University Hospital is an international cancer center with more than 100 cancer authoritative physicians, providing cancer patients with consultation, diagnosis, treatment, care, tracking and prevention in one place, as well as high-quality integrated medical services at all stages.

About Guang-Li Biomedicine

Guang-Li Biomedicine has been involved in cell research since 2009 and has worked with many medical institutions in Taiwan to conduct cell culture for patients with stroke and gradual freezing. The experimental center is committed to improving cell culture and treatment technologies such as immune cells, mesenchymal stem cells, and hematopoietic stem cells, and promotes the popularization of cell therapy, so that patients who have experienced pain can use cell therapy early to fight diseases such as malignant tumors.

More information please visit: https://guangli.com.tw

SOURCE Guang-Li Biomedicine Inc.

 

Media Contact Information:

Company: Guang-Li Biomedicine Inc.
Contact: Ting-Cheng Lin
E-mail: alic@guangli.com.tw
Phone: +886-2-2694-9880
Website: https://guangli.com.tw


More News From walkthebiz.com

Europe's specialty food makers brace for US tariffs

Dec 16, 2019

MILAN — European producers of premium specialty agricultural products like French wine, Italian Parmesan and Spanish olives are facing a U.S. tariff hike due Friday with a mix of trepidation and indignation at being dragged into a trade war they feel they have little to do with. The tariffs on $7.5 billion on a range of European goods were approved by the World Trade Organization as compensation for illegal EU subsidies to plane maker Airbus. The U.S. has some leeway in deciding what goods it puts tariffs on. So while it is taxing European aircraft goods an extra 10%, it...

The Latest: Pence heads to Mideast as Turkey attacks Kurds

Dec 16, 2019

WASHINGTON — The Latest on the United States and the military withdrawal from northern Syria (all times local): 6:20 p.m. Vice President Mike Pence says he's being dispatched to the Middle East by President Donald Trump as U.S. troops pull out of northeast Syria and Turkish forces invade. Pence says Trump spoke with Turkish leader Recep Tayyip Erdogan earlier Monday and called for an immediate end to Turkey's moves against the Kurds in Syria. Pence says the president is "very concerned about instability in the region" and is denying that Trump gave Turkey the green light to launch the invasion...

Asian stocks gain after US, China announce truce on tariffs

Dec 16, 2019

BEIJING — Asian stock markets have risen after Washington and Beijing announced a truce on tariff hikes in a trade war. Benchmarks in Shanghai, Hong Kong and Seoul advanced. Japanese markets were closed for a holiday. President Donald Trump agreed Friday to put off planned tariff hikes this week on Chinese goods in a fight over Beijing's trade surplus and technology plans. In exchange, he said China would buy American farm goods. But the two sides reported no progress on basic disputes that sparked the 15-month-old fight that threatens global economic growth. Friday's truce "has simply temporarily halted the escalation...

Impeachment dominates, but much other work awaits Congress

Dec 16, 2019

WASHINGTON — Impeachment may have leapfrogged to the top of the national agenda, but members of Congress still have their day jobs as legislators, and they're returning to work this week with mixed hopes of success. It's a difficult-to-predict time when it comes to possible deals between President Donald Trump and House Speaker Nancy Pelosi, who's kicked off the impeachment inquiry. An important trade agreement has a pulse. An effort to deal with prescription drug prices seems stuck. Divided government has produced scant results thus far, except for a small-scale budget deal that lawmakers are struggling to put in place....

Kosovo election winner in no rush to restart Serbia talks

Dec 16, 2019

PRISTINA, Kosovo — A left-wing party leader poised to become Kosovo's next prime minister said Tuesday he isn't in any rush to restart formal talks intended to normalize relations with Serbia and won't lift the previous government's 100% tariff on Serb imports. In a general election held Sunday, Albin Kurti's Movement for Self-the Determination, or Vetevendosje, defeated center-right political groupings formed by former Kosovo Liberation Army fighters who had governed since 2007. Kosovo, a former Serbian province, declared independence in 2008, a decade after an insurrection by KLA fighters and Serbian strongman Slobodan Milosevic's bloody crackdown launched a 1998-99 war....

Walk The Biz welcomes all casual and easygoing readers who seeks to digest business travel to international trade policy to starting in the transportation & shipping industry.

Subscribe to our newsletter now!

Name:

Email: